Explore more publications!

Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

Press releases published on January 8, 2026

Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
Best Creatine Supplements for Women And Men 2026: Effective Creatine For Muscle Growth & Weight loss For Women Over 40, 50 - by Crazy Nutrition
SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
AAFA Affirms Public Health Value of Vaccines as Nearly Everyone Is High Risk or Lives in Community with High Risk Individuals
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
Cellectis Announces 2026 Strategy and Catalysts
Cellectis annonce sa stratégie et ses jalons attendus en 2026
World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku’s “Orb” Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months
AAFA Affirms Public Health Value of Vaccines as Nearly Everyone Is High Risk or Lives in Community with High Risk Individuals
Spyre Therapeutics Announces Grants of Inducement Awards
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
ClinNEXUS Launches New Corporate Rebranding to Kick Off Attendance During Week of J.P. Morgan Healthcare Conference
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions